Medicines shortages-unpicking the evidence from a year in South Africa

Australasian Medical Journal

Volumn 7, Issue 5, 2014, Pages 208-212

  Gray, Andy ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Medicines shortages; Public sector selection and procurement; South Africa; Systems wide responses

Indexed keywords

ALUMINUM HYDROXIDE PLUS MAGNESIUM TRISILICATE; AMOXICILLIN PLUS CLAVULANIC ACID; CLOXACILLIN; DOXAZOSIN; ERYTHROMYCIN; GENERIC DRUG; GLYCOPYRRONIUM BROMIDE; ISOSORBIDE DINITRATE; PRAZOSIN; RABIES IMMUNOGLOBULIN;

ARTICLE; DRUG INDUSTRY; GOVERNMENT; HEALTH CARE; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH SERVICE; PERSONNEL SHORTAGE; PRACTICE GUIDELINE; PRIVATE PRACTICE; SOUTH AFRICA;

EID: 84902134702     PISSN: 18361935     EISSN: None     Source Type: Journal    
DOI: 10.4066/amj.2014.1932     Document Type: Article

References (15)

1. Charatan F. Prescription drug shortages plague US. BMJ 2001;322(7279):130 PMID: 11159566.
2. Gatesman ML, Smith TJ. The shortage of essential chemotherapy drugs in the United States. N Engl J Med 2011;365:1653-1655. doi:10.1056/ NEJMp1109772.
3. Chabner BA. Drug shortages-a critical challenge for the generic-drug market. N Engl J Med 2011;365:2147-2149. doi:10.1056/NEJMp1112633.
4. Jensen V, Rappaport BA. The reality of drug shortages- the case of the injectable agent propofol. N Engl J Med 2010;363:806-807. doi:10.1056/ NEJMp1005849.
5. Mirtallo JM. The drug shortage crisis. J Parenter Enteral Nutr 2011;35:433. doi:10.1177/0148607111412051.
6. Woodcock J, Wosinska M. Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther 2013;93(2):170-176. doi: 10.1038/clpt.2012.220.
7. Waning B, Diedrichsen E, Jambert E, Bärnighausen T, Li Y, Pouw M, et al. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr 2010;10:74. doi:10.1186/1471-2431-10-74.
8. Beerten E, Bonheure F. Autour du monde - des indisponsibilités de medicaments. Annales Pharmaceutiques Belges 2011;Nov 15:11-14. Cited in: Gray A and Manasse H, Shortages of medicines: a complex global challenge. Bulletin of the World Health Organisation 2012;90(3):158-158A. DOI:10.2471/BLT.11.101303.
9. Gupta DK, Huang S-M. Drug shortages in the United States: a critical evaluation of root causes and the need for action. Clin Pharmacol Ther 2013;93(2):133-135. doi: 10.1038/clpt.2012.229.
10. Fox ER, Tyler LS. Call to action: finding solutions for the drug shortage crisis in the United States. Clin Pharmacol Ther. 2013;93(2):145-147. doi: 10.1038/clpt.2012.225.
11. US Food and Drug Administration Safety and Innovation Act. Public Law 112-144. 9 July 2012. Accessible at http://www.gpo.gov/fdsys/pkg/PLAW-112publ144/pdf/PLAW-112publ144.pdf (accessed 22 August 2013).
12. Gray A, Manasse HR Jr. Shortages of medicines: a complex global challenge. Bull World Health Organ. 2012;90(3):158-158A. doi: 10.2471/BLT.11.101303.
13. International Pharmaceutical Federation. International Summit on Medicine Shortages concludes in Toronto with a call to action for stakeholders around the world. Press release 21 June 2012. Accessible at http://www.fip.org/www/index.php?page=news_publications&news=newsitem&newsitem=142 (accessed 22 August 2013).
14. Gray AL. Medicine pricing interventions - the South African experience. Southern Med Review 2009;2(2):15-19.
15. National Department of Health. Essential Drugs Programme. Accessible at http://www.doh.gov.za/healthtopicsor.php?t=Essential Drugs Programme (EDP) (accessed 22 August 2013).